MOVING LIFE SCIENCE INNOVATIONS 

FROM DISCOVERY TO DEVELOPMENT TO  DELIVERY

OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.

OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.

OUR MEMBERS: AZBio Members make an impact. They discover, develop and deliver health innovations including medicines, medical devices, diagnostics, and a wide range of health technologies. Our members also include economic development partners, educators, investors, leading business and philanthropic organizations, and patient advocacy organizations. AZBio Members employ over 365,000 Arizonans who are working together to make life better for people in Arizona and around the world.

Our industry sector generated over $43.64 billion in Economic Impact in 2023.

That's up over 88% from 2016 and growing at a Compound Annual Growth Rate of 9.5%.

Arizona’s bioscience industry (not including our hospitals) employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average.  View More of Arizona's Bioscience Industry Data

IN THE LOOP

AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.

Subscribe

AZBio Members Are Making LIFE Better

AZBio Members discover, develop, and deliver life-saving and life-changing innovations.

Premiere Supporters

Leadership Supporters

Sustaining Members

Get Connected With Arizona's Bioindustry

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.  

AZBio  Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector.  As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.

Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.

Success Stories – Good News from Arizona’s BioIndustry

U of A researchers team up to take on major health challenges

Researchers, clinicians and other experts from across the University of Arizona and Banner Health are bringing together expertise from medicine, engineering, pharmacy, science and other disciplines to tackle major health challenges and move promising health discoveries closer to patient care.

U of A celebrates milestone in Medical Innovations Building, announces new partnerships

University of Arizona leaders joined Phoenix Mayor Kate Gallego, members of the Arizona Board of Regents, Arizona health and community partners, and the construction team Wednesday afternoon to celebrate the placement of the final structural beam atop the new Medical Innovations Building, marking a major milestone in the university’s efforts to advance groundbreaking healthcare research.

Publication of ROADS Phase 3 Clinical Trial Data in Journal of Clinical Oncology Recommends GammaTile® as a New Standard-of-Care Option for Newly Diagnosed Operable Brain Metastases

Phase 3 trial results earn Rapid Communication status, underscoring the importance of the ROADS findings in clinical practice, with the trial authors endorsing GammaTile as a new standard-of-care option for newly diagnosed operable brain metastases1 GammaTile demonstrated 98.7% local tumor control by 12 months, compared to 84.6% for standard-of-care, reducing the risk of surgical bed […]

Events

AZBio Builds Relationships With Partners Across The Country

Partner Opportunities for AZBio Members